By S.J. Enna and Michael Williams (Eds.)
Every one quantity of Advances in Pharmacology offers a wealthy number of stories on well timed issues. Emphasis is put on the molecular foundation of drug motion, either utilized and experimental.Articles written by means of major investigators within the fieldInforms and updates on the entire most modern advancements
Read or Download Contemporary Aspects of Biomedical Research: Drug Discovery PDF
Similar nonfiction_3 books
Electrochromic fabrics, either natural and inorganic, have frequent purposes in light-attenuation, screens and research. Written in an available demeanour, this booklet presents a complete remedy of all kinds of electrochromic structures and their many functions. insurance develops from electrochromic scope and historical past to new looking shows of optical quantification and theoretical mechanistic versions.
Regardless of its organization with the nationwide, the trendy correct is a transnational phenomenon. even if in its fascist, conservative, or other kinds, it organizes throughout nationwide obstacles, connecting hobbies in several international locations. but this phenomenon has too usually been ignored via students, an oversight that this quantity seeks to right.
- Crossing Vines: A Novel (Chicana & Chicano Visions of the Americas, V. 2)
- Dishonest Woman
- Indeed I Love - Właśnie Kocham (Bilingual English-Polish edition)
- The Moses Tradition (JSOT Supplement Series)
Extra resources for Contemporary Aspects of Biomedical Research: Drug Discovery
Hoboken, NJ: Wiley. , & Fox, A. J. (2000). NK1 receptor antagonists – are they really without effect in the pain clinic? Trends in Pharmacological Sciences, 21, 462–464. Lefkowitz, R. J. (2004). Historical review: A brief history and personal retrospective of seven-transmembrane receptors. Trends in Pharmacological Sciences, 8, 413–422. Leventhal, A. , & Martell, C. R. (2005). The myth of depression as disease: Limitations and alternatives to drug treatment. Santa Barbara, CA: Praeger. Levin, E.
Perri, D. (2008). Primary prevention of cardiovascular mortality and events with statin treatments: A network meta-analysis involving more than 65,000 patients. Journal of the American College of Cardiology, 52, 1769–1781. Milne, G. , Jr. (2003). Pharmaceutical productivity – the imperative for new paradigms. Annual Reports in Medicinal Chemistry, 38, 383–396. , & Mori, T. (2007). Tolvaptan, an orally active vasopressin V2-receptor antagonist – pharmacology and clinical trials. Cardiovascular Drug Reviews, 25, 1–13.
2002). DNA microarrays: Boundless technology or bound by technology? Guidelines for studies using microarray technology. Arthtitis and Rheumatism, 46, 859–861. FitzGerald, G. A. (2005). Anticipating change in drug development: The emerging era of translational medicine and therapeutics. Nature Reviews. Drug Discovery, 4, 815–818. FitzGerald, G. A. (2007). Clinical pharmacology or translational medicine and therapeutics: Reinvent or rebrand and expand? Clinical Pharmacology and Therapeutics, 81, 17–18.